Centessa Pharmaceuticals Ownership | Who Owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals Ownership Summary
Centessa Pharmaceuticals is owned by 67.06% institutional investors, 0.53% insiders, and 32.41% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 14.88% of CNTA shares. Fidelity Select Biotechnology is the top mutual fund, with 1.51% of its assets in Centessa Pharmaceuticals shares.
CNTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Centessa Pharmaceuticals | 67.06% | 0.53% | 32.41% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 19.96M | 14.88% | $499.28M |
| Avoro capital advisors | 10.81M | 8.09% | $262.10M |
| Adage capital partners gp | 10.04M | 7.51% | $243.35M |
| Index venture life associates vi | 9.96M | 7.43% | $249.14M |
| General atlantic | 9.68M | 7.24% | $234.78M |
| Fmr | 6.28M | 4.70% | $152.22M |
| Janus henderson group | 4.91M | 4.22% | $82.22M |
| Price t rowe associates inc /md/ | 4.80M | 3.59% | $116.50M |
| Farallon capital management | 4.33M | 3.24% | $105.03M |
| First light asset management | 3.64M | 2.72% | $88.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Index venture life associates vi | 9.96M | 100.00% | $249.14M |
| Medicxi ventures management (jersey) | 19.96M | 59.80% | $499.28M |
| Foresite capital management vi | 1.31M | 12.31% | $31.86M |
| Allostery investments lp | 52.50K | 8.79% | $689.85K |
| First light asset management | 3.64M | 8.31% | $88.17M |
| General atlantic | 9.68M | 7.05% | $234.78M |
| 5am venture management | 680.95K | 6.05% | $16.51M |
| Saturn v capital management | 734.54K | 3.91% | $17.81M |
| Tcg crossover management | 3.14M | 3.74% | $76.06M |
| Avoro capital advisors | 10.81M | 3.39% | $262.10M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | 10.81M | 3.39% | 5.81M |
| Janus henderson group | 4.91M | 0.04% | 3.61M |
| Fmr | 6.28M | 0.01% | 2.45M |
| Perceptive advisors | 3.10M | 2.17% | 1.95M |
| Adage capital partners gp | 10.04M | 0.39% | 1.63M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vida ventures advisors | - | - | -3.93M |
| Holocene advisors, lp | - | - | -2.26M |
| Point72 asset management | 1.07M | 0.04% | -1.52M |
| Baker bros. advisors lp | - | - | -1.23M |
| Price t rowe associates inc /md/ | 4.80M | 0.01% | -1.10M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ecor1 capital | 550.00K | 0.64% | 550.00K | $13.34M |
| Logos global management lp | 525.00K | 1.14% | 525.00K | $12.73M |
| Wcm investment management | 257.19K | 0.01% | 257.19K | $6.36M |
| Jain global | 241.97K | 0.03% | 241.97K | $5.87M |
| Deutsche bank ag\ | 156.21K | 0.00% | 156.21K | $3.91M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -17.00 |
| Bell investment advisors | -31.00 |
| Caldwell sutter capital | -43.00 |
| Spire wealth management | -70.00 |
| Washington trust advisors | -184.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 103 | -26.95% | 89,972,752 | -29.89% | 67 | 0.73% | 56 | -11.11% | 32 | -36.00% |
| Sep 30, 2025 | 140 | 10.24% | 128,318,654 | 3.84% | 95 | 1.11% | 62 | -11.43% | 50 | 47.06% |
| Jun 30, 2025 | 126 | -10.00% | 123,550,297 | -0.00% | 92 | 1.08% | 69 | -9.21% | 34 | -8.11% |
| Mar 31, 2025 | 141 | 18.49% | 124,864,870 | 0.36% | 93 | 0.82% | 75 | 22.95% | 38 | - |
| Dec 31, 2024 | 118 | 11.32% | 124,412,240 | 14.59% | 107 | 1.23% | 60 | -21.05% | 38 | 137.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 2.23M | 1.51% | -104.20K |
| T. Rowe Price Health Sciences | 2.19M | 1.48% | -172.24K |
| Fidelity Select Health Care | 1.60M | 1.08% | 40.00K |
| Federated Hermes Kaufmann Growth | 1.24M | 0.84% | 350.70K |
| Federated Hermes Kaufmann R | 1.24M | 0.84% | 350.70K |
| American Funds SMALLCAP World A | 1.14M | 0.77% | 452.11K |
| Polar Capital Biotech S Inc | 1.00M | 0.75% | - |
| Federated Hermes Kaufmann Small Cap A | 1.08M | 0.73% | 239.70K |
| Federated Hermes Kaufmann Small Cap Grow | 1.08M | 0.73% | 239.70K |
| Franklin Biotechnology Discv A(acc)USD | 1.06M | 0.72% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 02, 2026 | HUSSAIN IQBAL J | Chief Legal Officer | Sell | $979.66K |
| Jan 30, 2026 | HUSSAIN IQBAL J | Chief Legal Officer | Sell | $25.26K |
| Dec 09, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $213.28K |
| Dec 09, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $75.01K |
| Dec 08, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $300.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 2 |
| 2025 Q4 | - | 8 |
| 2025 Q3 | - | 14 |
| 2025 Q2 | 2 | 12 |
| 2025 Q1 | - | 18 |
CNTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools